Management of Dyspepsia in Patients Over 55 Without Alarm Features or Treatment-Resistant Symptoms
For patients over 55 years old with dyspepsia but no alarm features and no treatment-resistant symptoms, proceed directly with H. pylori testing ("test and treat") followed by empirical acid suppression therapy—endoscopy is NOT indicated in this scenario. 1
Clinical Algorithm
Step 1: Initial Laboratory Testing
- Obtain a full blood count in all patients ≥55 years with dyspepsia 1
- Check coeliac serology only if overlapping IBS-type symptoms are present 1
Step 2: Test and Treat for H. pylori
- Perform non-invasive H. pylori testing (urea breath test, stool antigen test, or validated serology) 1
- If positive: provide eradication therapy (typically 7-day triple therapy with PPI + clarithromycin + amoxicillin or metronidazole) 1, 2
- Confirmation of eradication is only needed in patients at increased risk of gastric cancer 1
Step 3: Empirical Acid Suppression
- If H. pylori negative OR symptoms persist after successful eradication: initiate PPI therapy at standard dose for 4-8 weeks 1
- PPIs are strongly recommended as first-line treatment with high-quality evidence 1
- No dose-response benefit exists, so use the lowest effective dose 1
Step 4: Response Assessment
- If symptoms resolve: stop treatment after 4-8 weeks 3
- If symptoms recur: repeat the same treatment course 3
- If inadequate response after 2-4 weeks: consider changing drug class or dosing 3
When Endoscopy IS NOT Indicated
Critical distinction: The 2022 BSG guidelines clearly state that non-urgent endoscopy is only considered in patients ≥55 years with:
- Treatment-resistant dyspepsia (symptoms persisting despite appropriate therapy), OR
- Dyspepsia with raised platelet count, OR
- Dyspepsia with nausea or vomiting 1
Your patient does NOT meet these criteria since they have no treatment-resistant symptoms and no alarm features.
Important Caveats
Age Threshold Nuance
While the guidelines use age ≥55 as a threshold for various recommendations, urgent endoscopy is only warranted at this age if accompanied by:
- Weight loss (definite alarm feature) 1
- Family history of gastro-oesophageal cancer 1
- Origin from high gastric cancer risk area 1
The "Test-and-Scope" Controversy
Recent evidence suggests that in H. pylori-positive patients over 55, even without alarm symptoms, endoscopy may identify advanced gastric atrophy (OLGA stages III-IV) in approximately 1.4% of cases 4. However, current BSG guidelines do not support routine endoscopy in this population without treatment resistance or other specific indications 1.
Common Pitfall to Avoid
Do not confuse "age ≥55" alone as an indication for endoscopy. The guidelines require additional factors (alarm symptoms, treatment resistance, or specific laboratory abnormalities) beyond age alone 1. Studies show that 81.8% of gastroscopies performed for dyspepsia have no alarm symptoms, and many are done inappropriately in younger patients, but the same principle applies—age plus benign presentation does not mandate endoscopy 5.
Establish Effective Communication
- Explain that functional dyspepsia is the most likely diagnosis (present in ~80% of investigated dyspepsia cases) 1
- Describe FD as a disorder of gut-brain interaction, not a psychological condition 1
- Discuss symptom triggers, natural history, and the role of diet, stress, and behavioral factors 1
- This empathic approach reduces healthcare utilization and improves quality of life 1
If Initial Treatment Fails
Only after documented treatment resistance (failure of H. pylori eradication if positive AND failure of empirical PPI therapy) should you consider:
- Non-urgent endoscopy 1
- Second-line therapies: tricyclic antidepressants (start amitriptyline 10 mg daily, titrate to 30-50 mg) 1
- Referral to gastroenterology for specialist evaluation 1
The key message: Your patient's age alone, without treatment resistance or alarm features, does not warrant endoscopy—proceed with medical management first. 1